dopamine agonists
Showing 51 - 75 of 1,399
Glucagon-like Peptide-1 Receptor Agonists According to Type 2
Recruiting
- Diabetes Mellitus, Type 2
- GLP-1 receptor agonist
-
Bari, ItalyAzienda Ospedaliero-Universitaria Policlinico Bari
Nov 4, 2023
Exercise Performance Trial in Copenhagen (Vilanterol and Fluticasone Furoate, Indacaterol and Mometasone Furoate, Placebo)
Recruiting
- Exercise Performance
- Vilanterol and Fluticasone Furoate
- +2 more
-
Copenhagen, DenmarkAugust Krogh Building
Oct 4, 2023
MSA - Multiple System Atrophy Trial in Oxford (Deep brain stimulation)
Recruiting
- MSA - Multiple System Atrophy
- Deep brain stimulation
-
Oxford, Oxfordshire, United KingdomJohn Radcliffe Hospital
Jan 5, 2022
Healthy Trial in Copenhagen (Exercise)
Withdrawn
- Healthy
- Exercise
-
Copenhagen, NV, DenmarkDepartment of Respiratory Medicine, L, Bispebjerg Hospital,
Feb 27, 2023
Opioid-Induced Constipation Trial in Leuven (Naloxegol, codeine phosphate, Placebo)
Completed
- Opioid-Induced Constipation
- Naloxegol
- +2 more
-
Leuven, Vlaams-Brabant, BelgiumUZ Leuven
Mar 15, 2023
Functional Relevance of Dopamine Receptors in Healthy Controls
Recruiting
- Schizoaffective Disorder
- Schizophrenia
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
Restless Legs Syndrome Trial in Peoria (Magnesium Citrate)
Recruiting
- Restless Legs Syndrome
- Magnesium Citrate
-
Peoria, IllinoisOSF Healthcare Illinois Neurological Institute
Jun 10, 2021
Glaucoma, Suspect, Aberration, Corneal Wavefront Trial in Banha (Low dosage selective alpha-2 receptor agonists topical eyedrop,
Recruiting
- Glaucoma, Suspect
- Aberration, Corneal Wavefront
- Low dosage selective alpha-2 receptor agonists topical eyedrop
- High dosage selective alpha-2 receptor agonists topical eyedrop
-
Banhā, QA, EgyptAhmed Abdelshafy
Jan 2, 2023
Uncontrolled Asthma Trial (Experimental: CHF6001 3200 µg, Placebo Comparator: CHF6001 Placebo)
Not yet recruiting
- Uncontrolled Asthma
- Experimental: CHF6001 3200 μg
- Placebo Comparator: CHF6001 Placebo
- (no location specified)
Sep 7, 2023
Effect of Sulpiride on Working Memory Gating and Associated BOLD Signal in the Striatum, Effect of Sulpiride on the Influence of
Completed
- Effect of Sulpiride on Working Memory Gating and Associated BOLD Signal in the Striatum
- +2 more
- Sulpiride 400 MG
- Placebo
-
Nijmegen, Gelderland, NetherlandsDonders Centre for Cognition, Radboud University
May 22, 2023
MDD Trial in Shanghai (Toludesvenlafaxine HCl sustained-release tablets)
Not yet recruiting
- Major Depressive Disorder
- Toludesvenlafaxine hydrochloride sustained-release tablets
-
Shanghai, Shanghai, ChinaShanghai Mental Health Center
Sep 7, 2023
Healthy Trial in Zürich (Psilocybin, 3,4 Methylenedioxymethamphetamine, Methylphenidate)
Recruiting
- Healthy
- Psilocybin
- +2 more
-
Zürich, SwitzerlandPsychiatrische Universitätsklinik Zürich
Oct 3, 2023
Depressive Disorder, Major Trial (L-dopa/Carbidopa, Placebo)
Not yet recruiting
- Depressive Disorder, Major
- L-dopa/Carbidopa
- Placebo
- (no location specified)
Jun 11, 2023
Health Trial in Edmonton (Dopamine, Metoclopramide, Placebos)
Recruiting
- Health
- Dopamine
- +5 more
-
Edmonton, Alberta, CanadaClinical Physiology Research Laboratory
Apr 6, 2022
MDD Trial in Shanghai (Toludivenlafaxine HCl sustained-release tablets)
Recruiting
- Major Depressive Disorder
- Toludivenlafaxine hydrochloride sustained-release tablets
-
Shanghai, Shanghai, ChinaShanghai Mental Health Center
Jun 14, 2023
Morbid Obesity, Metabolic Syndrome, Diabetes Trial in Columbia (GLP-1 receptor agonist)
Not yet recruiting
- Morbid Obesity
- +4 more
- GLP-1 receptor agonist
-
Columbia, MissouriUniversity of Missouri Hospital
Nov 20, 2023
Healthy Trial (single-dose madopar, single-dose propranolol, and single-dose by order, single-dose madopar, single-dose , and
Not yet recruiting
- Healthy
- single-dose madopar, single-dose propranolol, and single-dose placebo by order
- +5 more
- (no location specified)
Sep 13, 2023
Adrenoleukodystrophy, Restless Legs Syndrome Trial in Boston, Amsterdam (Pramipexole, Placebo)
Not yet recruiting
- Adrenoleukodystrophy
- Restless Legs Syndrome
- Pramipexole
- Placebo
-
Boston, Massachusetts
- +1 more
Aug 5, 2021
Glucagon-like Peptide 1 Receptor Agonists and Mental Health
Not yet recruiting
- Diabetes Mellitus
- +2 more
- GLP-1 receptor agonist
- (no location specified)
Aug 4, 2022
Gastric Ultrasound Assessment for Patients Taking GLP1 Agonists
Not yet recruiting
- Gastric Ultrasound
- +2 more
- Gastric Ultrasound Exam
- (no location specified)
Aug 15, 2023
Type 2 Diabetes Trial in Lancaster (Exenatide Injection, Saline injection)
Terminated
- Type 2 Diabetes
- Exenatide Injection
- Saline injection
-
Lancaster, PennsylvaniaAmish Research Clinic
Mar 6, 2023
Effect and Mechanism of Dopamine on Ulcerative Colitis
Recruiting
- Dopamine Dysregulation Syndrome
- Ulcerative Colitis
- Patients diagnosed with ulcerative colitis
-
Beijing, Beijing, ChinaThe Fifth Medical Center of Chinese PLA General Hosptial
Feb 28, 2022
Oropharyngeal Dysphagia, Swallowing Disorder Trial in Mataró (Capsaicin, Piperine, Placebo)
Not yet recruiting
- Oropharyngeal Dysphagia
- Swallowing Disorder
- Capsaicin
- +2 more
-
Mataró, Barcelona, SpainHospital de Mataró
Jul 14, 2023
COPD Greek Patients Based on Standard Clinical Practice.
Not yet recruiting
- Copd
- COPD Exacerbation
- (no location specified)
Jun 22, 2022